Wells Fargo’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $248K | Sell |
107,234
-1,814
| -2% | -$4.19K | ﹤0.01% | 4260 |
|
|
2025
Q1 | $152K | Buy |
109,048
+5,664
| +5% | +$7.87K | ﹤0.01% | 4423 |
|
|
2024
Q4 | $179K | Buy |
103,384
+31,457
| +44% | +$54.4K | ﹤0.01% | 4381 |
|
|
2024
Q3 | $145K | Buy |
71,927
+2,185
| +3% | +$4.39K | ﹤0.01% | 4399 |
|
|
2024
Q2 | $156K | Buy |
69,742
+62,334
| +841% | +$140K | ﹤0.01% | 4313 |
|
|
2024
Q1 | $21.3K | Sell |
7,408
-21
| -0.3% | -$60 | ﹤0.01% | 5175 |
|
|
2023
Q4 | $13.1K | Buy |
7,429
+889
| +14% | +$1.57K | ﹤0.01% | 5320 |
|
|
2023
Q3 | $20.7K | Sell |
6,540
-12,653
| -66% | -$40K | ﹤0.01% | 5219 |
|
|
2023
Q2 | $12.7K | Buy |
19,193
+15,148
| +374% | +$10K | ﹤0.01% | 5545 |
|
|
2023
Q1 | $3.23K | Buy |
4,045
+2,777
| +219% | +$2.22K | ﹤0.01% | 5826 |
|
|
2022
Q4 | $2.87K | Buy |
1,268
+318
| +33% | +$719 | ﹤0.01% | 5593 |
|
|
2022
Q3 | $2K | Buy |
950
+787
| +483% | +$1.66K | ﹤0.01% | 5870 |
|
|
2022
Q2 | $1K | Sell |
163
-1,282
| -89% | -$7.87K | ﹤0.01% | 6315 |
|
|
2022
Q1 | $9K | Sell |
1,445
-8,014
| -85% | -$49.9K | ﹤0.01% | 5966 |
|
|
2021
Q4 | $110K | Buy |
+9,459
| New | +$110K | ﹤0.01% | 5183 |
|
|
2021
Q2 | – | Sell |
-57,412
| Closed | -$1.17M | – | 7030 |
|
|
2021
Q1 | $1.17M | Buy |
57,412
+44,971
| +361% | +$913K | ﹤0.01% | 3892 |
|
|
2020
Q4 | $330K | Buy |
+12,441
| New | +$330K | ﹤0.01% | 4709 |
|